UNITED STATES PHARMACOPEIAL CONVENTION (USP)

Lobbying Spend

—

Filings

Firms Hired

Active Period

2019–2022

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2022	—	3	1
2021	—	4	1
2020	—	5	1
2019	—	4	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
CAPITOL HILL CONSULTING GROUP	—	16

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
Centers For Medicare and Medicaid Services (CMS)	15
Health & Human Services, Dept of (HHS)	15
Food & Drug Administration (FDA)	13

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	16

UNITED STATES PHARMACOPEIAL CONVENTION (USP) — Lobbying Disclosure | Poliscope